» Articles » PMID: 25752747

Designing Clinical Trials for Amblyopia

Overview
Journal Vision Res
Specialty Ophthalmology
Date 2015 Mar 11
PMID 25752747
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Randomized clinical trial (RCT) study design leads to one of the highest levels of evidence, and is a preferred study design over cohort studies, because randomization reduces bias and maximizes the chance that even unknown confounding factors will be balanced between treatment groups. Recent randomized clinical trials and observational studies in amblyopia can be taken together to formulate an evidence-based approach to amblyopia treatment, which is presented in this review. When designing future clinical studies of amblyopia treatment, issues such as regression to the mean, sample size and trial duration must be considered, since each may impact study results and conclusions.

Citing Articles

The prevalence of functional amblyopia and its related risk factors in preschool children in North-Eastern Iran.

Hamidi A, Jalalifar S, Atigh S, Darvishi A, Moghadas Sharif N, Lashkardoost H Oman J Ophthalmol. 2024; 17(1):59-64.

PMID: 38524325 PMC: 10957057. DOI: 10.4103/ojo.ojo_295_22.


Factors predicting regression of visual acuity following successful treatment of anisometropic amblyopia.

Jia Y, Liu J, Ye Q, Zhang S, Feng L, Xu Z Front Med (Lausanne). 2022; 9:1013136.

PMID: 36388932 PMC: 9659723. DOI: 10.3389/fmed.2022.1013136.


Efficacy of interventions for amblyopia: a systematic review and network meta-analysis.

Li Y, Sun H, Zhu X, Su Y, Yu T, Wu X BMC Ophthalmol. 2020; 20(1):203.

PMID: 32450849 PMC: 7249307. DOI: 10.1186/s12886-020-01442-9.


The Effect of Combined Patching and Citalopram on Visual Acuity in Adults with Amblyopia: A Randomized, Crossover, Placebo-Controlled Trial.

Lagas A, Black J, Russell B, Kydd R, Thompson B Neural Plast. 2019; 2019:5857243.

PMID: 31281343 PMC: 6590556. DOI: 10.1155/2019/5857243.


'It's too late'. Is it really? Considerations for amblyopia treatment in older children.

Piano M, Simmers A Ther Adv Ophthalmol. 2019; 11:2515841419857379.

PMID: 31259304 PMC: 6585235. DOI: 10.1177/2515841419857379.


References
1.
Cotter S, Edwards A, Wallace D, Beck R, Arnold R, Astle W . Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006; 113(6):895-903. PMC: 1790727. DOI: 10.1016/j.ophtha.2006.01.068. View

2.
Scheiman M, Hertle R, Beck R, Edwards A, Birch E, Cotter S . Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005; 123(4):437-47. DOI: 10.1001/archopht.123.4.437. View

3.
Stewart C, Stephens D, Fielder A, Moseley M . Objectively monitored patching regimens for treatment of amblyopia: randomised trial. BMJ. 2007; 335(7622):707. PMC: 2001048. DOI: 10.1136/bmj.39301.460150.55. View

4.
Repka M, Kraker R, Beck R, Holmes J, Cotter S, Birch E . A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol. 2008; 126(8):1039-44. PMC: 2614351. DOI: 10.1001/archopht.126.8.1039. View

5.
Scheiman M, Hertle R, Kraker R, Beck R, Birch E, Felius J . Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol. 2008; 126(12):1634-42. PMC: 2846774. DOI: 10.1001/archophthalmol.2008.107. View